Anti-Malarial Drug Resistance in Cameroon

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

755

Participants

Timeline

Start Date

August 31, 2003

Study Completion Date

May 31, 2005

Conditions
Malaria
Interventions
DRUG

Amodiaquine and Sulphadoxine/Pyrimethamine

All Listed Sponsors
collaborator

University of Yaounde

OTHER

lead

London School of Hygiene and Tropical Medicine

OTHER

NCT00146718 - Anti-Malarial Drug Resistance in Cameroon | Biotech Hunter | Biotech Hunter